General MedicationsPOWDER,FOR SOLUTIONStandard
PIPERACILLIN AND TAZOBACTAM
PIPERACILLIN,TAZOBACTAM
Standard Dose
3.0G
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PIPERACILLIN AND TAZOBACTAM is listed in Drugs@FDA under application 217409 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PIPERACILLIN,TAZOBACTAM Form and strength INJECTION;POWDER,FOR SOLUTION - 3.0G Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-12-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview PIPERACILLIN AND TAZOBACTAM is listed in Drugs@FDA under application 217409 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PIPERACILLIN,TAZOBACTAM Form and strength INJECTION;POWDER,FOR SOLUTION - 3.0G Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-12-03 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.